1. Innovation & Simplicity
for our clients
success!

2. Our Heritage
Established
since 1984
We assist
 Business Intelligence to achieve a deep
knowledge of the Market, Customer and
Brand.
Over  Commercial Operation to maximise
performance and the return on their
investments.
120 projects per year 

Innovators to create more successful
propositions.
CEO’s to grow profits through customer-
centricity.
40% International Rome Some HQ Credentials Special
Milan & P&G Relationship
others 18 Pfizer
countries Forest
through our Daiichi-Sankyo
MEDINET Johnson & Johnson Univ. “La Sapienza”
Novo Nordisk NOMOS
network
€ 151.000 average Eurogroup
SIIA, SID, SIP,
sales per person/year AIOM, etc...

3. MEDI-PRAGMA CAPABILITIES
Coverage of both Availability of applied
qual and quant statistical capability
research
Consulting attitude
Strong project
management
…and also knowledge on the therapeutic area
Valerio Carboniero: Offering for Metabolic & CV disease, device, Francesca Venturi Visconti: Offering for Vaccines, Antibiotics,
customer satisfactions & brand tracking Parallel Imports, value proposition & communication test
Quantitative Research Director Qualitative Research Manager
Vincenzo Falco: Offering for Oncology, Hematology, Orphan Drugs & Bruno Sfogliarini: Offering for Forecasting, Marketing Mix,
Market Access Segmentation & Targeting, Market Potential
R&D Manager Medi-Pragma Nord Director
Lucio Carsana: Offering for SFE, Selling skills, Field manager coach Gokay Ustun: Offering for Transplant, Hemophilia & Rheumatoid
Business Development arthritis
Alfonso Martuscelli: Offering for Vaccines, Mature Products, Business Development
Hemophilia & CNS Emanuele Corsaro: Offering for Pharmacy, Wholesalers & OTC
Field Manager International Account Manager

4. METHODOLOGIES FOR DATA COLLECTION
Bespoke – Tailored - Flexible
DATA COLLECTION IS CARRIED
OUT EXCLUSIVELY BY
ESPECIALLY TRAINED AND
BRIEFED QUALIFIED PERSONNEL
(MEDICAL DOCTORS,
BIOLOGISTS, PSYCHOLOGISTS,
PROFESSIONAL INTERVIEWERS)

5. MEDI-PRAGMA VALUE FOR OUR CLIENTS

6. OUR OFFERINGS FOR PHARMA
Knowledge
Commercial
Research
Effectiveness
Strategy
Consultant
Business
Solution

7. OUR OFFERINGS FOR PHARMA
MARKET POTENTIAL/DEFINITION MARKETING MIX OPTIMIZATION RELATIONSHIP
PRODUCTS/BRAND LCM SEGMENTATION & TARGETING INTELLIGENCE
PHARMA SOLUTION
CUSTOMER POTENTIAL MARKET ACCESS IN BOUND & OUT BOUND
PROJECT
CUSTOMER/ PRODUCT VALUE
PROPOSITION BUSINESS MODEL DRUGS DEVELOPMENT VALUE CHAIN
COMPANY/BRAND
IDENTITY/COMMUNICATION/IMAGE/ CALL QUALITY SALES CAMPAIGN PLANNING
REPUTATION & DEPLOYMENT
MKT/COMPETITIVE
INTELLIGENCE & GAP ANALYSIS NON PERSONAL PROMOTION

8. THERE YOU HAVE IT: FOURTEEN MARKET RESEARCH
OPTIONS THAT ARE NOT “TRADITIONAL” METHODS
Fourteenisalot,sotocategorize themethods, usethetable below.Thecategories areself-explanatory, andareausefulwaytodrawdistinctions.
METODOLOGIES WHEN USE MEDI-PRAGMA ANALYTICS TOOL
ECONOMETRICS ROI, KPI, PERFORMANCE ASSESTMENT, GAP ANALYSIS, MARKETING MIX ALLOCATION, ROMI, SHIFT SHARE, EVENT IMPACT, SoV, SELETRACK, TRAXER
MS, PATIENTS INCIDENCE & PREVALENCE, SCENARIOUS
INTANGIBLE METRICS ROI, BRAND VALUE & POSITIONING, KPI, VALUE PROPOSITION, IMPACT OF REPUTACTION,IDEA, SoV, SELETRACK, TRAXER, KANO MODEL, FI.DO
INNOVATION, GAP ANALYSIS, MARKETING MIX ALLOCATION, PERFORMANCE
ASSESTMENT, AWARENESS
EMOTIOMETRICS BRAND VALUE, POSITIONING, EFFECTIVENESS OF MESSAGES, VALUE PROPOSITION, EXCELLENCE CIRCLE, EMOTIONAL SELLING, SOCIAL AWARENESS, KANO MODEL,
COMMUNICATION CHANNEL SET UP, CUSTOMER INFLUENCE T.O.T.E. , TRAXER
NEUROMARKETING BRAND VALUE, POSITIONING, EFFECTIVENESS OF MESSAGES, VALUE PROPOSITION, EYE TRACKING, FACIAL CODING
COMMUNICATION CHANNEL SET UP, CUSTOMER INFLUENCE
ENGAGEMENT BRAND PIRAMID: AWARENESS, ASSOCIATION, FAMILIARITY, ATTITUDES, IDENTITY, STRUCTURAL EQUATION MODEL, AMOS, TRAXER
PERSONALITY, IMAGE, PREFERENCE, POSITION, EQUITY-CONCEPT TESTING
EXPERT INTERVIEW VALUE PROPOSITION, SCENARIOUS, COMMUNICATION CHANNEL SET UP, LATERAL KOLABORATION, STAKHOLABORATION,
THINKING, NEW NEEDS DESCOVERY, GAP ANALYSIS, DEFIND BARRIERS TO ACCESS LADDERING, SIX HATS FG, ANALYTIC HIERARCHY PROCESS
ETNOGRAPHIC SOURCE OF BUSINESS, SWITCHES DINAMICS, PATIENTS LIFE STORY, COMPLIANCE VIDEO LAB, PHARMA MISTERY SHOPPING, VESPRO, “24: Twenty for you”
DIGITAL MARKETING SOCIAL MEDIA, NON PERSONAL PROMOTION, E-DETAILING, E-MARKETING, E-REPS, BUZZ SENTIMENT, EYE TRACKING, WEB ANALYTICS, E-BIZZ SATISFACTION, REP
RESEARCH VIRAL MARKETING, AWARENESS EQUIVALENT MODEL
FORECASTING SCENARIOUS, RISK AND UNCERTAINTY, DECISION ANALYSIS FORECASTING TOOL, SIMULATION TECHNIQUES, WATERFALL DIAGRAMM, …
TEXT ANALITICS VALUE PROPOSITION, SCENARIOUS, COMMUNICATION CHANNEL SET UP, LATERAL Nvivo9, LEXICON, WORDERING ANALYTICS
THINKING, NEW NEEDS DESCOVERY, AWARENESS
MROCS VALUE PROPOSITION, SCENARIOUS, COMMUNICATION CHANNEL SET UP, LATERAL DELPHI ONLINE, KOLMUNNITY, ANALYTIC HIERARCHY PROCESS
THINKING, NEW NEEDS DESCOVERY
NEW CUSTOMER PROFILING & COSTUMER SEGMENTATION & TARGETING BASED ON VALUE PROPOSITION AND/OR CLUSTER ANALYSIS, MANOVA, DISCRIMINANT ANALYSIS, CONJOINT ANALYSIS,
MAPPING VOLUMETRICS ATTITUDE, DEFIND BARRIERS TO ACCESS STAKEHOLDERS NETWORKING & INFLUENCE, I-PHARM DATA BASE,
CORRESPONDENCE MAPPING ANALYSIS, MULTIDIMENSIONAL SCALING (MDS)
HOLISTIC BRAND VALUE, POSITIONING, EFFECTIVENESS OF MESSAGES, VALUE PROPOSITION, HALL TEST, STORY BOARD & SELLING, HOLLYWOOD, SIX HATS FG, TERRITORY FG,
COMMUNICATION CHANNEL SET UP, DEFIND BARRIERS TO ACCESS, AWARENESS, KANO MODEL, SELETRACK, TRAXER
LOYALTY, CONCEPT TEST
TRANSFORMATIONAL TO EVELUATE INTERNAL STAFF, DESCOVER AREA OF IMPROVING, BUILD A GOOD ICQ, CMC, STRACOM, ASSERTIVITY, CHANGE MANAGEMENT, REP’S EMPATY
LEARNING HUMAN ENVIRONMENT, ANALYZE MANAGEMENT SYSTEMS AND LEADERSHIP STYLE

9. MAIN CLIENTS
Dermatology
3%
Sales Force Effectiveness Others
17% 10%
Cardiovascular
Consumer 20%
11%
Rheumatology
5%
Gastrointestinal
CNS/Psychiatry
4%
10%
Oncology
Diabetes
10% Medical Device
5%
5%

10. N° OF INT’S STUDIES
OVER THE PAST
70
60
66
50
40
30
53
20
31 45
10
0
2007 2008 2009 2010

11. COUNTRIES INVOLVED
7,0%
10,0%
25,0%
UK
SPAIN
GERMANY
20,0% FRANCE
18,0%
USA
OTHER
20,0%

13. Challenge your agencies Knowledge Research Strategy
Commercial Effectiveness
Intelligence Business Solution